Company Overview of Light Sciences Oncology, Inc.
Light Sciences Oncology, Inc. develops Talaporfin sodium for the treatment of solid tumors and other indications in patients. Its Talaporfin sodium is a water-soluble drug targeted by a small, single-use, and disposable drug activator that is included with the drug, and is used for the treatment of patients with hepatocellular carcinoma, metastatic colorectal cancer, and benign prostatic hyperplasia/enlargement of the prostate. The company was founded in 1994 and is based in Bellevue, Washington.
12600 SE 38th Street
Bellevue, WA 98006
Founded in 1994
Key Executives for Light Sciences Oncology, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Light Sciences Oncology, Inc., please visit www.lsoncology.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.